Pharmacogenomics aims to rationalize drug use by minimizing drug toxicity and / or by increasing...
Not exact matches
The Genomics and
Pharmacogenomics Working Group aims to undertake and coordinate research projects that will facilitate the integration of genomics applications and pharmacogenomics
Pharmacogenomics Working Group
aims to undertake and coordinate research projects that will facilitate the integration of genomics applications and
pharmacogenomics pharmacogenomics into healthcare.
The Sections
aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug - related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical
pharmacogenomics.
This section invites manuscripts describing (a) Linkage, association, substitution or positional mapping and epigenetic studies in any species; (b) Validation studies of candidate genes using genetically - engineered mutant model organisms; (c) Studies focused on epistatis and gene - environment interactions; (d) Analysis of the functional implications of genomic sequence variation and
aim to attach physiological or
pharmacogenomic relevance to alterations in genes or proteins; (e) Studies of DNA copy number variants, non-coding RNA, genome deletions, insertions, duplications and other single nucleotide polymorphisms and their relevance to physiology or pharmacology in humans or model organisms, in vitro or in vivo; and (f) Theoretical approaches to analysis of sequence variation.
ESHG's Gene - Patenting Guidelines
Aim to Protect Innovation and Patient Access
Pharmacogenomics Reporter - Apr 30, 2008